Skip to main content
Top

Current Atherosclerosis Reports

Issue 10/2015

Content (6 Articles)

Lipid and Metabolic Effects of Gastrointestinal Surgery (R Cohen, Section Editor)

Changes in Reward after Gastric Bypass: the Advantages and Disadvantages

Samantha Scholtz, Anthony P. Goldstone, Carel W. le Roux

Open Access Lipid and Metabolic Effects of Gastrointestinal Surgery (R Cohen, Section Editor)

The Obese Brain—Effects of Bariatric Surgery on Energy Balance Neurocircuitry

José Carlos de Lima-Júnior, Lício A. Velloso, Bruno Geloneze

Lipid and Metabolic Effects of Gastrointestinal Surgery (R Cohen, Section Editor)

Clinical Management of Type 2 Diabetes Mellitus after Bariatric Surgery

Vishesh Khanna, Sangeeta R. Kashyap

Lipid and Metabolic Effects of Gastrointestinal Surgery (R Cohen, Section Editor)

Metabolic Surgery in Type 2 Diabetes: Roux-en-Y Gastric Bypass or Sleeve Gastrectomy as Procedure of Choice?

Josep Vidal, Amanda Jiménez, Ana de Hollanda, Lílliam Flores, Antonio Lacy

Clinical Trials and Their Interpretations (J Kizer, Section Editor)

Catheter-based Renal Artery Denervation for Resistant Hypertension: Promise Unfulfilled or Unsettled?

Matthew G. Denker, Debbie L. Cohen, Raymond R. Townsend

Nonstatin Drugs (E deGoma, Section Editor)

ApoA-I-Directed Therapies for the Management of Atherosclerosis

John S. Millar, Marina Cuchel

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine